why choose us

First received: October 12, 2022

Clinical Trial: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Previously Treated Primary Immune Thrombocytopenia

Study Type: INTERVENTIONAL


Official Title: Comparing the Efficacy and Safety of Optimized rhTPO Treatment Versus Eltrombopag Treatment in Previously Treated Primary Immune Thrombocytopenia Patients: A Multicenter Randomized Open-label Trial

Brief Summary: TE-ITP study: Compare the efficacy and safety of optimized rhTPO treatment versus Eltrombopag treatment in previously treated primary immune thrombocytopenia patients.

Read more